Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1518 Articles

Lee Jackson | Nov 30, 2017 at 10:00 AM EST

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

One area to look at in this overbought and pricey market is pharmaceuticals. These five now are considered to be…

Chris Lange | Nov 10, 2017 at 11:25 AM EST

Short Sellers Back Way Off Major Pharma

The October 31 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Lee Jackson | Nov 10, 2017 at 10:15 AM EST

Biosimilars Have Massive Sales Potential: 5 Top Drug Stocks to Buy Now

Merrill Lynch points to five companies that, in their words, should be key players in the young but growing biosimilar…

Chris Lange | Oct 31, 2017 at 10:15 AM EDT

Pfizer Earnings Not Enough for Investors

When Pfizer released its third-quarter earnings report before the markets opened on Tuesday, the results and guidance lived up to…

Chris Lange | Oct 30, 2017 at 11:15 AM EDT

What to Expect When Pfizer Reports Earnings

Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.

Chris Lange | Oct 29, 2017 at 10:25 AM EDT

Facebook, Alibaba and More Major Earnings to Look For This Week

The busiest earnings week of the season has come and gone, but there are still plenty more big names stepping…

Chris Lange | Oct 28, 2017 at 10:05 AM EDT

Top Biopharma Events Coming by the End of 2017

24/7 Wall St. has collected a few pharma and biotech catalysts that are coming up on the calendar in November…

Chris Lange | Oct 25, 2017 at 10:20 AM EDT

Short Sellers Hike Bets in Major Pharma

The October 13 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Oct 25, 2017 at 6:10 AM EDT

The 6 Most Shorted NYSE Stocks

Among the most shorted stocks traded on the New York Stock Exchange, two struggling retailers saw notable growth in their…

Jon C. Ogg | Oct 24, 2017 at 12:25 PM EDT

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

Here are 13 featured spin-offs already underway and potential spin-offs that could be seen in 2017 and into 2018 that…

Chris Lange | Oct 11, 2017 at 10:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 29 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Sep 27, 2017 at 9:00 AM EDT

Major Pharma Short Interest Piles On

The September 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 26, 2017 at 12:10 PM EDT

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech…

Paul Ausick | Sep 20, 2017 at 4:01 PM EDT

McDonald’s Lifts, Apple Weighs on DJIA Wednesday

Apple and 3M weighed on the DJIA Wednesday while McDonald's and Pfizer gave the index a boost.

Paul Ausick | Sep 14, 2017 at 4:01 PM EDT

United Technologies, Pfizer Lead DJIA Higher on Thursday

United Technologies, Pfizer, Merck, and Boeing were the stalwarts among the DJIA index stocks on Thursday.

1 … 40 41 42 43 44 … 102

Pfizer : PFE

All Pfizer Articles

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

Short Sellers Back Way Off Major Pharma

Biosimilars Have Massive Sales Potential: 5 Top Drug Stocks to Buy Now

Pfizer Earnings Not Enough for Investors

What to Expect When Pfizer Reports Earnings

Facebook, Alibaba and More Major Earnings to Look For This Week

Top Biopharma Events Coming by the End of 2017

Short Sellers Hike Bets in Major Pharma

The 6 Most Shorted NYSE Stocks

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

Short Sellers Run for Cover From Major Pharma

Major Pharma Short Interest Piles On

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

McDonald’s Lifts, Apple Weighs on DJIA Wednesday

United Technologies, Pfizer Lead DJIA Higher on Thursday

She’s Land-Rich but Cash-Poor at 64. A Deal for the Farm’s Development Rights Could Let Her Delay Social Security to 70.

The Average Social Security Check Is $2,082. Your Bills Didn’t Get the Memo. These 4 ETFs Step In

What It Takes to Retire to Delaware’s Beaches at 62 on $800,000 and Skip Florida Entirely

At 62, His Woods Became a Maple Syrup Business. What the Income Does to His Social Security.

She's Land-Rich but Cash-Poor at 64. A Deal for the Farm's Development Rights Could Let Her Delay Social Security to 70.

At 62, His Woods Became a Maple Syrup Business. What the Income Does to His Social Security.

She’s Land-Rich but Cash-Poor at 64. A Deal for the Farm’s Development Rights Could Let Her Delay Social Security to 70.

Pfizer : PFE

All Pfizer Articles

Merrill Lynch Bullish on Deep Value Pharmaceuticals: 5 Stocks to Buy for 2018

Short Sellers Back Way Off Major Pharma

Biosimilars Have Massive Sales Potential: 5 Top Drug Stocks to Buy Now

Pfizer Earnings Not Enough for Investors

What to Expect When Pfizer Reports Earnings

Facebook, Alibaba and More Major Earnings to Look For This Week

Top Biopharma Events Coming by the End of 2017

Short Sellers Hike Bets in Major Pharma

The 6 Most Shorted NYSE Stocks

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

Short Sellers Run for Cover From Major Pharma

Major Pharma Short Interest Piles On

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

McDonald’s Lifts, Apple Weighs on DJIA Wednesday

United Technologies, Pfizer Lead DJIA Higher on Thursday

She’s Land-Rich but Cash-Poor at 64. A Deal for the Farm’s Development Rights Could Let Her Delay Social Security to 70.

The Average Social Security Check Is $2,082. Your Bills Didn’t Get the Memo. These 4 ETFs Step In

What It Takes to Retire to Delaware’s Beaches at 62 on $800,000 and Skip Florida Entirely

Featured Reads

At 62, His Woods Became a Maple Syrup Business. What the Income Does to His Social Security.

She's Land-Rich but Cash-Poor at 64. A Deal for the Farm's Development Rights Could Let Her Delay Social Security to 70.